vimarsana.com

Page 206 - ஒன்றுபட்டது கிஂக்டம் உச்ச நீதிமன்றம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Olaplex, L Oréal lose Fed Circuit appeals over haircare patent

Olaplex, L’Oréal lose Fed Circuit appeals over haircare patent 29-01-2021 19-11-2019 Both L Oréal and Olaplex have failed to convince the US Court of Appeals for the Federal Circuit to overturn a decision on keratin treatment patent claims. In a decision issued yesterday, January 28 the court affirmed a Patent Trial and Appeal Board (PTAB) decision invalidating key claims of an Olaplex patent. But despite an appeal from L Oréal, other claims of the patent remain valid. Keratin treatments are usually used to smoothe or treat frizzy hair. Olaplex and L Oréal have been wrapped up in litigation over patents covering types of keratin treatments since early 2017.

X gender-neutral passport case to go before Supreme Court in July

Non-gendered campaigner Christie Elan-Cane has fought for social and legal recognition for 30 years. A long-running legal fight for ‘X’ gender markers on passports will be heard by the UK Supreme Court in July. The case, which was first heard by the High Court in 2018, is brought by campaigner Christie Elan-Cane, who has fought for legal and social recognition as a person of non-gendered identity for almost three decades. Applicants for a UK passport must indicate whether they are male or female in a signed declaration. Elan-Cane argues that it is discriminatory for the UK Home Office to refuse to offer passports with an ‘X’ gender marker for people who are not male or female, such as non-binary people.

The Financial Conduct Authority v Arch and Others [2021] UKSC 1 ( the FCA Test Case ) | Zelle LLP

To read this article in PDF format, please click here. On 15 January 2021 the UK Supreme Court handed down its highly anticipated judgment in the FCA Test Case.  The COVID-19 pandemic has forced the UK Government to introduce public health measures which have resulted in significant losses for many businesses.  Many businesses have turned to their business interruption insurance policies to indemnify them for their losses.  Insurers have often declined cover, insisting that the policies do not respond to the economic impact of the pandemic.  The Financial Conduct Authority (“the FCA”), as the UK’s insurance regulator, stepped in to represent the interests of the policyholders and was the named claimant in the Test Case.

Don t Be Fooled by the Numbers: How Insurance Companies Are Attempting to Create a False Narrative on COVID-19 Insurance Claims | Pillsbury - Policyholder Pulse blog

To embed, copy and paste the code into your website or blog: Since the novel coronavirus landed in America, the insurance industry has worked hard to create the impression that there is no coverage for business interruption losses resulting from the pandemic. For the most part, insurers have discussed the “intent” of the policies and avoided specific policy analysis. The insurer disinformation effort recently started including citations to lists of court decisions obtained to date as if insurance coverage should be decided not on the terms of the contracts at issue but instead on the basis of an early win/loss record. A review of court statistics, along with two recent court decisions, expose the fallacy of the insurers’ argument.

Oppression versus derivative actions: courts wide discretion maintained

Section 346 of the Companies Act 2016 provides the courts with broad powers to grant remedies as they deem necessary to bring an end to the complaints raised in an oppression action. In Lee Kai Wuen v Lee Yee Wuen,(1) the Federal Court refused leave to appeal the Court of Appeal s decision which had found that the courts powers in an oppression action are broad and unfettered. This includes the power to order restitution to a company, a remedy traditionally seen as belonging to companies. Facts The subject company had two shareholders. The plaintiff (the majority shareholder) filed an oppression action against the other shareholder and a third party (the oppressors), anchored on, among other things, an allegation of misappropriation of company funds. According to the plaintiff, upon the hospitalisation and eventual death of the previous majority shareholder, the oppressors had conspired to have the creditors pay them monies which were supposed to be paid to the company. The plai

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.